10.02.2013 Views

Presentation Outline ICHP Annual Meeting September 13-15

Presentation Outline ICHP Annual Meeting September 13-15

Presentation Outline ICHP Annual Meeting September 13-15

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

T/F: Rifapentine in combination with<br />

isoniazid had a greater rate of<br />

hepatotoxicity than did isoniazid alone.<br />

A. True<br />

B. False<br />

Questions?<br />

References<br />

• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease. CHEST.<br />

2012;141(2_suppl):e419S‐e494S.<br />

• Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz, JI. Antiplatelet drugs. CHEST.<br />

2012;141(2_suppl):e89S‐e119S.<br />

• Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous<br />

thromboembolism. N Engl J Med. 2012;366(21):1959‐1967.<br />

• Mehta SR , Bassand JP, Chrolavicius S et al; CURRENTOASIS 7 Investigators. Dose comparisons<br />

of clopidogreland aspirin in acute coronary syndromes. syndromes N Engl J Med .2010 2010 ;363(10): 930‐942 930 942<br />

• Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of<br />

cardiovascular death. N Engl J Med. 2012;366(20):1881‐1889.<br />

• Owens RC Jr, Nolin TD. Antimicrobial‐associated QT interval prolongation: pointes of interest.<br />

Clin Infect Dis. 2006;43(12):1603‐1611.<br />

• PL Detail‐Document. Hormonal contraceptives and the risk of thrombosis. Pharmacists’<br />

Letter/Prescriber’s Letter. August 2012: #280804.<br />

8/30/2012<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!